Navigation Links
Auxilium Pharmaceuticals, Inc. and BioSpecifics Technologies Corp. Announce Plans to Develop Additional Indications using XIAFLEX®
Date:8/31/2011

ained in the forward-looking statements. Given these risks and uncertainties, any or all of these forward-looking statements may prove to be incorrect. Therefore, you should not rely on any such factors or forward-looking statements.

In addition, forward-looking statements provide Auxilium's expectations, plans or forecasts of future events and views as of the date of this release. Auxilium anticipates that subsequent events and developments will cause Auxilium's assessments to change. However, while Auxilium may elect to update these forward-looking statements at some point in the future, Auxilium specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing Auxilium's assessments as of any date subsequent to the date of this release.

Auxilium disclaims responsibility for statements above in "About BioSpecifics", which were provided by BioSpecifics for inclusion in this release.

BioSpecifics Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Any statements, other than statements of historical fact, including statements regarding BioSpecifics' strategy, future operations, future financial position, future revenues, projected costs, prospects, plans and objectives of management, its expected revenue growth, and any other statements containing the words "believes," "expects," "anticipates," "plans," "estimates" and similar expressions, are forward-looking statements. There are a number of important factors that could cause its actual results to differ materially from those indicated by such forward-looking statements, including the statements made by BioSpecifics concerning the likelihood of success of future clinical trials in new indications, and other risk factors identified in the BioSpecifics' Form 10-K for the year ended December 31, 2010 and its reports on Form 8-K filed wi
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Auxilium Pharmaceuticals Announces Investor Event to Occur at 2011 ASSH Meeting on September 9, 2011
2. Auxilium Pharmaceuticals to Present at the Stifel Nicolaus 2011 Healthcare Conference
3. Auxilium Pharmaceuticals, Inc. Announces Promotion of Dr. James P. Tursi to Chief Medical Officer
4. Auxilium Pharmaceuticals to Announce Second Quarter 2011 Results and Conduct Conference Call on Monday, August 1, 2011
5. Auxilium Pharmaceuticals Announces Results from Three Year CORDLESS Extension Study in Dupuytrens Contracture
6. Auxilium Pharmaceuticals to Present at the Bank of America Merrill Lynch 2011 Health Care Conference
7. Auxilium Pharmaceuticals to Present at the Deutsche Bank 36th Annual Health Care Conference
8. Auxilium Pharmaceuticals, Inc. Announces Launch of XIAPEX® in EU by Pfizer
9. Auxilium Pharmaceuticals, Inc. and Asahi Kasei Pharma Corporation Enter Agreement to Develop, Commercialize and Supply XIAFLEX® In Japan
10. Auxilium Pharmaceuticals, Inc. Completes Enrollment of XIAFLEX® Phase III Double-Blind Studies for Peyronies Disease
11. Auxilium Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... PLAINFIELD, N.J. , May 16, 2013  PTC ... registration statement on Form S-1 with the U.S. Securities ... public offering of its common stock. The number of ... the offering have not been determined. (Logo:  ... Credit Suisse are acting as joint book-running managers for ...
(Date:5/16/2013)... N.C. , May 16, 2013  Today, the ... North Carolina House of Representatives recently approved ... for chemotherapy from charging patients higher out-of-pocket fees for ... formularies, many of which have more severe side-effects. However, ... limit of $300, which will continue to be a ...
(Date:5/16/2013)... May 16, 2013  Alere Inc. (NYSE: ALR ... of their health at home through the merger of rapid ... $3.00 per share on its Series B Convertible Perpetual Preferred ... 2013 to holders of record of Series B stock at ... Such payment will cover the amount of all dividends accrued ...
Breaking Medicine Technology:PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 2National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 3
... Calif., Dec. 12 BioForm Medical,Inc. (Nasdaq: ... multi-center,randomized, blinded comparative study of nasolabial fold treatments,reporting ... reported after treatment with either Juvederm(TM) or Perlane(R). ... December 2007 Filler Issue of,the Journal of Dermatologic ...
... Solvay Pharmaceuticals, Inc.,announced today that the company ... and Drug Administration (FDA) to fully address the ... in its meeting to,consider tedisamil as a treatment ... normal sinus rhythm (NSR)., The Committee voted ...
Cached Medicine Technology:Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 2Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 3Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 4Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 5Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 6Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation 2
(Date:5/18/2013)... 2013 The “Sleep Apnea Diagnostic & ... Masks, Adaptive Servo-Ventilation (ASV), Oral Appliances, Nasal EPAP, Neurostimulation] ... analyzes and studies the major market drivers, restraints, and ... the World. , Browse , ... Figures , 318 pagesand in-depth TOC ...
(Date:5/18/2013)... Show And Go Training, the culmination of Eric Cressey’s ... is all about is getting results in the fastest amount ... ’s Stan Stevenson, prompting an investigative review. , “ ... system” designed to make you faster, stronger, fitter and trimmer ... in the gym. The training manual and exercise video database ...
(Date:5/18/2013)... Morro Bay, CA (PRWEB) May 18, 2013 ... salon , has recently completed a stylish renovation that ... and advanced specialties. , From the ground up, this ... been improved with fresh flooring, soothing colors and comfortable ... have been installed, including an Apilus epilator machine. ...
(Date:5/18/2013)... 18, 2013 Dr. Robert Tracey, an area ... employs his knowledge of the root causes of sleep ... With May being Better Sleep Month, Dr. Tracey points out ... chronic sleep disorder, and sleep apnea is one of the ... person will essentially stop breathing at different times while sleeping. ...
(Date:5/18/2013)... May 18, 2013 The topics that will ... scrum framework, scrum roles, scrum meetings, scrum artifacts, and scrum ... PDUs) for attending them. , These trainings are suitable for ... also ideal for those who will be a part of ... who want to explore Agile and Scrum, but are unsure ...
Breaking Medicine News(10 mins):Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 2Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 3Health News:Show And Go Training: Review Examining Eric Cressy's Workout Program Revealed 2Health News:Rio Salon and Spa, a Beauty Salon in Morro Bay, Undergoes Makeover 2Health News:Pomona, NY Dentist, Dr. Robert Tracey of General & Laser Assisted Dentistry (GLAD) Highlights Sleep Apnea Dentistry Services for Better Sleep Month 2Health News:Pomona, NY Dentist, Dr. Robert Tracey of General & Laser Assisted Dentistry (GLAD) Highlights Sleep Apnea Dentistry Services for Better Sleep Month 3Health News:Affordable Scrum Trainings In Irvine by Conscires Agile Practices 2Health News:Affordable Scrum Trainings In Irvine by Conscires Agile Practices 3
... believe a brain imaging approach that combines standard ... techniques could lead to more effective diagnoses in ... the brain. ,James Leach, MD, reports ... American Journal of Neuroradiology. This is the first ...
... mutations of the gene responsible for the debilitating ... study claims to make treatment more specific for ethnic groups ... by genetic tests. , Says Irwin McLean ... University of Dundee, who led the study:” Once we cracked ...
... are describing as a “ U-turn of dramatic proportions”, a ... can in fact prevent// them from the risks of heart ... of the American Medical Association shows that hormone replacement therapy ... put such women at higher risks of heart attacks and ...
... least 2,500 years old. It claims to be the world's oldest inhabited ... ,Its population of 1.74 millions is said to be living ... is a scarce commodity, whatever water is available is soaked up by ... with cheeks bulging bizarrely as they get their fix. It is a ...
... be worth over $200 million and is expected to grow to ... ,The growth of the food industry is also going ... industry, which is currently growing at nine percent. ,These ... food meet to be held in New Delhi April 10-11, which ...
... even faster than the climate around it since the late ... of 2040//, according to a study by professors at ... largest freshwater lake in the world by surface area. ... increased about 4.5 degrees since 1979, compared with about a ...
Cached Medicine News:Health News:Combined Imaging Approach may Be Effective in Diagnosing Some Brain Clots 2Health News:More Mutations Of Gene That Cause Skin Disorders And Asthma Discovered 2Health News:Hormone Replacement Therapy- Not A Fallen Angel 2Health News:Drug Uses Up Water in Yemeni Capital, People Must Relocate 2
Table mount stabilizer system...
The specially designed table-mounted stepper/stabilizer offers the strength and stability necessary for a flawless delivery of brachytherapy....
... Nd:YAG laser system with a wavelength of 1,064 ... superficial as well as red and blue vein ... patients with darker skin types (1 to 6) ... general improvement of skin texture. The handpieces special ...
... SINON is a Q-switched ... wavelength of 694 nm. High ... Pulses - This combination of ... pulses in Q-switched mode effectively ...
Medicine Products: